We chose Ashwagandha, a shrub prevalent in South and Central Asia and Africa, for this month’s featured herb because of its increasing popularity among cancer patients.

The Society for Integrative Oncology (SIO) is accepting nominations from SIO members to fill three anticipated vacancies on its Board of Trustees. SIO welcomes the nomination of individuals who are researchers, clinicians, clinical researchers, patients and patient advocates. The submission deadline is September 10, 2016. Learn more below about eligibility and submission procedures.

American ginseng was chosen for this month’s featured herb because of its increasing use by cancer patients. The Herb of the Month is presented by Memorial Sloan Kettering Cancer Center.Ginseng American 1

American ginseng is a perennial herb native to eastern North America. Following its introduction to China three centuries ago, both the fresh and dried forms of its root remain popular in Traditional Chinese medicine to enhance stamina and to treat a variety of ailments. Available evidence shows a modest protective effect of the herb in reducing the number and severity of colds, and in improving working memory in healthy adults. American ginseng has also been shown to improve cancer-related fatigue in cancer survivors - link to the MSKCC monograph.

WEB Herb Green TeaWe chose green tea this month because of its continued popularity around the world as an antioxidant. A beverage consumed worldwide for its purported health benefits, green tea is derived from the leaves of the plant Camellia sinensis. It has a long history of use in traditional medicine as a stimulant, diuretic, for wound healing, and to improve heart health. Currently, green tea and its extracts are utilized to prevent and treat hyperlipidemia, hypertension, atherosclerosis and cancer. Green tea has been shown to exert chemopreventive effects, and clinical trials are underway to determine its benefits in cancer care. Read more about green tea in the MSKCC monograph.